Progress of Non-Disabling Ischemic Cerebrovascular Events

doi:10.3969/j.issn.1673-5765.2018.04.021

Abstract

Abstract:

Non-disabling ischemic cerebrovascular events is the most common cerebrovascular disease, which usually be ignored because of its clinical manifestation is lighter. However, more and more studies have identified its characteristics of the high recurrence rate and poor prognosis. It is considered to be "Early Warning" stroke event which is serious and worthy of clinical emergency intervention. This paper reviews the concept, epidemiology, risk assessment and treatment of nondisabling cerebrovascular diseases.

Key words: Non-disabling ischemic cerebrovascular events; Minor stroke; Risk assessment; Review

摘要：

非致残性脑血管疾病是脑血管病最常见的类型，但因其临床表现较轻，以往常常被忽视，但越来越多研究已证实其复发率高、预后差的特点，被认为是临床上严重的、值得紧急干预的“卒中预警”事件。本文对非致残性脑血管疾病的概念、流行病学、风险评估及治疗的相关研究进展进行综述。

关键词: 非致残性脑血管疾病; 轻型卒中; 风险评估; 综述

ZHU Hong-Lu, SONG Yan-Li, WANG Tian-Gang, LI Zhao, LIN Jie, WU Yi-Ping. Progress of Non-Disabling Ischemic Cerebrovascular Events[J]. Chinese Journal of Stroke, 2018, 13(04): 402-408.

朱弘璐, 宋彦丽, 王天罡, 李朝, 林杰, 武一平. 非致残性脑血管疾病研究进展[J]. 中国卒中杂志, 2018, 13(04): 402-408.

References

[1] EASTON J D，SAVER J L，ALBERS G W，et al.

Definition and evaluation of transient ischemic attack：

a scientific statement for healthcare professionals

from the American Heart Association/American

Stroke Association Stroke Council；Council on

Cardiovascular Surgery and Anesthesia；Council on

Cardiovascular Radiology and Intervention；Council

on Cardiovascular Nursing；and the Interdisciplinary

Council on Peripheral Vascular Disease. The

American Academy of Neurology affirms the

value of this statement as an educational tool for

neurologists[J]. Stroke，2009，40（6）：2276-2293.

[2] FISCHER U，BAUMGARTNER A，ARNOLD M，

et al. What is a minor stroke?[J]. Stroke，2010，41（4）：

661-666.

[3] MERINO J G，LATOUR L L. The Boston Acute

Stroke Imaging Scale：ready for use in clinical

practice?[J]. Nat Clin Pract Neurol，2008，4（11）：

592-593.

[4] WANG Y，CUI L，JI X，et al. The China

National Stroke Registry for patients with acute

cerebrovascular events：design，rationale，and

baseline patient characteristics[J]. Int J Stroke，2011，

6（4）：355-361.

[5] WANG Y，ZHAO X，JIANG Y，et al. Prevalence，

knowledge，and treatment of transient ischemic

attacks in China[J]. Neurology，2015，84（23）：

2354-2361.

[6] VALLS J，PEIRO-CHAMARRO M，CAMBRAY S，

et al. A current estimation of the early risk of stroke

after transient ischemic attack：a systematic review

and meta-analysis of recent intervention studies[J].

Cerebrovasc Dis，2017，43（1-2）：90-98.

[7] WU L，WANG A，WANG X，et al. Factors for

short-term outcomes in patients with a minor stroke：

results from China National Stroke Registry[J/OL].

BMC Neurol，2015，15：253. https：//doi.org/10.1186/

s12883-015-0505-z

[8] MARENCO P，LAVALLÉE P C，LABREUCHE J，

et al. One-year risk of stroke after transient ischemic

attack or minor stroke[J]. N Engl J Med，2016，374

（16）：1533-1542.

[9] FERRARI J，KNOFLACH M，KIECHL S，et al.

Early clinical worsening in patients with TIA or

minor stroke：the Austrian Stroke Unit Registry[J].

Neurology，2010，74（2）：136-141.

[10] MUREN M A，HÜTLER M，HOOPER J.

Functional capacity and health-related quality of

life in individuals post stroke[J]. Top Stroke Rehabil，

2008，15（1）：51-58.

[11] WOLF T J，ROGNSTAD M C. Changes in cognition

following mild stroke[J]. Neuropsychol Rehabil，

2013，23（2）：256-266.

[12] VAN DER HAM I J，KANT N，POSTMA A，et

al. Is navigation ability a problem in mild stroke

patients? Insights from self-reported navigation

measures[J]. J Rehabil Med，2013，45（5）：429-433.

[13] FENS M，VAN HEUGTEN C M，BEUSMANS G

H，et al. Not as transient：patients with transient

ischaemic attack or minor stroke experience

cognitive and communication problems；an

exploratory study[J]. Eur J Gen Pract，2013，19（1）：

11-16.

[14] RADMAN N，STAUB F，ABOULAFIA-BRAKHA T，et al. Poststroke fatigue following minor infarcts：

a prospective study[J]. Neurology，2012，79（14）：

1422-1427.

[15] ALTIERI M，MAESTRINI I，MERCURIO A，et

al. Depression after minor stroke：prevalence and

predictors[J]. Eur J Neurol，2012，19（3）：517-521.

[16] ROTHWELL P M，GILES M F，FLOSSMANN E，

et al. A simple score（ABCD）to identify individuals

at high early risk of stroke after transient ischaemic

attack[J]. Lancet，2005，366（9479）：29-36.

[17] JOHNSTON S C，ROTHWELL P M，NGUYENHUYNH

M N，et al. Validation and refinement of

scores to predict very early stroke risk after transient

ischaemic attack[J]. Lancet，2007，369（9558）：283-

292.

[18] TSIVGOULIS G，STAMBOULIS E，SHARMA

V K，et al. Multicenter external validation of the

ABCD2 score in triaging TIA patients[J]. Neurology，

2010，74（17）：1351-1357.

[19] GALVIN R，GERAGHTY C，MOTTERLINI N，et

al. Prognostic value of the ABCD² clinical prediction

rule：a systematic review and meta-analysis[J]. Fam

Pract，2011，28（4）：366-376.

[20] YANG J，FU J H，CHEN X Y，et al. Validation of

the ABCD2 score to identify the patients with high

risk of late stroke after a transient ischemic attack

or minor ischemic stroke[J]. Stroke，2010，41（6）：

1298-1300.

[21] CHU T，YU W，WANG Y，et al. The ABCD2 score

may underestimate the short-term risk of stroke

in Chinese population：a meta-analysis[J]. Neuro

Endocrinol Lett，2015，36（3）：262-268.

[22] GALVIN R，ATANASSOVA P A，MOTTERLINI

N，et al. Long-term risk of stroke after transient

ischaemic attack：a hospital-based validation of the

ABCD² rule[J/OL]. BMC Res Notes，2014，7：281.

https：//doi.org/10.1186/1756-0500-7-281

[23] APPELROS P，HÁLS BERGLUND M，STRÖM J

O. Long-term risk of stroke after transient ischemic

attack[J]. Cerebrovasc Dis，2016，43（1-2）：25-30.

[24] MERWICK Á，ALBERS G W，AMARENCO P，

et al. Addition of brain and carotid imaging to the

ABCD² score to identify patients at early risk of

stroke after transient ischaemic attack：a multicentre

observational study[J]. Lancet Neurol，2010，9（11）：

1060-1069.

[25] KIYOHARA T，KAMOUCHI M，KUMAI Y，et al.

ABCD3 and ABCD3-I scores are superior to ABCD2

score in the prediction of short- and long-term risks

of stroke after transient ischemic attack[J]. Stroke，

2014，45（2）：418-425.

[26] KERNAN W N，VISCOLI C M，BRASS L M，et

al. The stroke prognosis instrument Ⅱ（SPI-Ⅱ）：a

clinical prediction instrument for patients with

transient ischemia and nondisabling ischemic

stroke[J]. Stroke，2000，31（2）：456-462.

[27] GILES M F，ALBERS G W，AMARENCO P，et

al. Addition of brain infarction to the ABCD2 Score

（ABCD2Ⅰ）：a collaborative analysis of unpublished

data on 4574 patients[J]. Stroke，2010，41（9）：1907-

1913.

[28] LINDSAY A C，BIASIOLLI L，LEE J M，et al.

Plaque features associated with increased cerebral

infarction after minor stroke and TIA：a prospective，

case-control，3-T carotid artery MR imaging

study[J]. JACC Cardiovasc Imaging，2012，5（4）：

388-396.

[29] COUTTS S B，MODI J，PATEL S K，et al. CT/CT

angiography and MRI findings predict recurrent

stroke after transient ischemic attack and minor

stroke：results of the prospective CATCH study[J].

Stroke，2012，43（4）：1013-1017.

[30] HORTON M，MODI J，PATEL S K，et al.

Refinement of imaging predictors of recurrent

events following transient ischemic attack and minor

stroke[J/OL]. PLoS One，2013，8（6）：e65752. https：

//doi.org/10.1371/journal.pone.0065752

[31] ZHANG C，ZHAO X，WANG C，et al. Prediction

factors of recurrent ischemic events in one year

after minor stroke[J/OL]. PLoS One，2015，10

（3）：e0120105. https：//doi.org/10.1371/journal.

pone.0120105

[32] LIU L，WONG K S，LENG X，et al. Dual

antiplatelet therapy in stroke and ICAS：Subgroup

analysis of CHANCE[J]. Neurology，2015，85（13）：

1154-1162.

[33] COUTTS S B，ELIASZIW M，HILL M D，et al. An

improved scoring system for identifying patients at

high early risk of stroke and functional impairment

after an acute transient ischemic attack or minor

stroke[J]. Int J Stroke，2008，3（1）：3-10.

[34] LI J，WANG Y，WANG D，et al. Glycated albumin

predicts the effect of dual and single antiplatelet

therapy on recurrent stroke[J]. Neurology，2015，84

（13）：1330-1336.

[35] LI J，WANG Y，LIN J，et al. Soluble CD40L is a

useful marker to predict future strokes in patients

with minor stroke and transient ischemic attack[J].

Stroke，2015，46（7）：1990-1992.

[36] LIN J，ZHENG H，CUCCHIARA B L，et al.

Association of Lp-PLA2-A and early recurrence

of vascular events after TIA and minor stroke[J]. Neurology，2015，85（18）：1585-1591.

[37] KENNEDY J，HILL M D，RYCKBORST K J，et

al. Fast assessment of stroke and transient ischaemic

attack to prevent early recurrence（FASTER）：a

randomised controlled pilot trial[J]. Lancet Neurol，

2007，6（11）：961-969.

[38] GEEGANAGE C，DIENER H C，ALGRA A，et al.

Dual or mono antiplatelet therapy for patients with

acute ischemic stroke or transient ischemic attack：

systematic review and meta-analysis of randomized

controlled trials[J]. Stroke，2012，43（4）：1058-1066.

[39] WANG Y，WANG Y，ZHAO X，et al. [CHANCE]

Clopidogrel with aspirin in acute minor stroke or

transient ischemic attack[J]. N Engl J Med，2013，

369（1）：11-19.

[40] GOUYA G，ARRICH J，WOLZT M，et

al. Antiplatelet treatment for prevention of

cerebrovascular events in patients with vascular

diseases：a systematic review and meta-analysis[J].

Stroke，2014，45（2）：492-503.

[41] JOHNSTON S C，EASTON J D，FARRANT M，

et al. Platelet-oriented inhibition in new TIA and

minor ischemic stroke（POINT）trial：rationale and

design[J]. Int J Stroke，2013，8（6）：479-483.

[42] WONG K S，WANG Y，LENG X，et al. Early dual

versus mono antiplatelet therapy for acute noncardioembolic

ischemic stroke or transient ischemic

attack：an updated systematic review and metaanalysis[

J]. Circulation，2013，128（15）：1656-1666.

[43] WANG Y，PAN Y，ZHAO X，et al. Clopidogrel with

aspirin in acute minor stroke or transient ischemic

attack（CHANCE）trial：one-year outcomes[J].

Circulation，2015，132（1）：40-46.

[44] ZHANG Q，WANG C，ZHENG M，et al. Aspirin

plus clopidogrel as secondary prevention after stroke

or transient ischemic attack：a systematic review

and meta-analysis[J]. Cerebrovasc Dis，2015，39（1）：

13-22.

[45] GE F，LIN H，LIU Y，et al. Dual antiplatelet therapy

after stroke or transient ischaemic attack - how long

to treat? The duration of aspirin plus clopidogrel in

stroke or transient ischaemic attack：a systematic

review and meta-analysis[J]. Eur J Neurol，2016，23

（6）：1051-1057.

[46] MERETOJA A，PUTAALA J，TATLISUMAK T，et

al. Off-label thrombolysis is not associated with poor

outcome in patients with stroke[J]. Stroke，2010，41

（7）：1450-1458.

[47] SMITH E E，FONAROW G C，REEVES M J，et al.

Outcomes in mild or rapidly improving stroke not

treated with intravenous recombinant tissue-type

plasminogen activator：findings from Get With The

Guidelines-Stroke[J]. Stroke，2011，42（11）：3110-

3115.

[48] KHATRI P，TAYAMA D，COHEN G，et al. Effect

of intravenous recombinant tissue-type plasminogen

activator in patients with mild stroke in the Third

International Stroke Trial-3：post hoc analysis[J].

Stroke，2015，46（8）：2325-2327.

[49] ROMANO J G，SMITH E E，LIANG L，et al.

Outcomes in mild acute ischemic stroke treated with

intravenous thrombolysis：a retrospective analysis

of the Get With the Guidelines-Stroke registry[J].

JAMA Neurol，2015，72（4）：423-431.

[50] LOGALLO N，KVISTAD C E，NAESS H，et al.

Mild stroke：safety and outcome in patients receiving

thrombolysis[J]. Acta Neurol Scand Suppl，2014，129

（198）：37-40.